Back

Insight into left ventricular diastolic compensation in hypertrophic cardiomyopathy with left ventricular outflow obstruction: a 4D flow CMR study

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Advanced cardiac magnetic resonance imaging in hypertrophic cardiomyopathy Flow Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Liang Zhong

National Heart Centre Singapore, Singapore (Singapore)

5 More presentations in this session

Presentation thumbnail
Diagnostic performance of cardiac diffusion tensor imaging in subclinical hypertrophic cardiomyopathy: a comparison with strain analysis
Doctor M. Asad (Manchester, GB)
Abstract Slides Video
Presentation thumbnail
Machine learning algorithms for predicting arrhythmic events in hypertrophic cardiomyopathy: limited enhancement beyond late gadolinium enhancement
Doctor J. Certo Pereira (Carnaxide, PT)
Abstract Slides Video
Presentation thumbnail
The prognostic value of right ventricular kinetic energy for predicting adverse events in hypertrophic cardiomyopathy
Professor L. Zhong (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Evaluation of genotype-phenotype correlation in hypertrophic cardiomyopathy using radiomic analysis of cardiac magnetic resonance
Doctor L. Tassetti (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of left atrioventricular coupling index for the prediction of adverse cardiac outcomes in patients with hypertrophic cardiomyopathy
Doctor S. Titichoatrattana (Bangkok, TH)
Abstract Slides Video

Access the full session

Session thumbnail
Advanced cardiac magnetic resonance imaging in hypertrophic cardiomyopathy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
New imaging insights into hypertrophic cardiomyopathy
thumbnail
Congress Session
Emerging concepts in hypertrophic cardiomyopathy (HCM)
thumbnail
Congress Session
Redefining hypertrophic cardiomyopathy in the myosin inhibitor era

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources